10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.62
-0.52 (-2.25%)
At close: Mar 3, 2026, 4:00 PM EST
22.14
-0.48 (-2.12%)
After-hours: Mar 3, 2026, 6:49 PM EST

10x Genomics Stock Forecast

Stock Price Forecast

The 14 analysts that cover 10x Genomics stock have a consensus rating of "Hold" and an average price target of $17.18, which forecasts a -24.05% decrease in the stock price over the next year. The lowest target is $6.50 and the highest is $25.

Price Target: $17.18 (-24.05%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$6.50$17.18$19$25
Change-71.26%-24.05%-16.00%+10.52%

Analyst Ratings

The average analyst rating for 10x Genomics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy332222
Buy332222
Hold568999
Sell000000
Strong Sell111111
Total121313141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel
Stifel
Strong Buy
Maintains
$20$25
Strong BuyMaintains$20$25+10.52%Mar 2, 2026
UBS
UBS
Hold
Maintains
$14$20
HoldMaintains$14$20-11.58%Feb 20, 2026
Stifel
Stifel
Strong Buy
Maintains
$15$20
Strong BuyMaintains$15$20-11.58%Feb 13, 2026
TD Cowen
TD Cowen
Hold
Maintains
$18$19
HoldMaintains$18$19-16.00%Feb 13, 2026
Leerink Partners
Leerink Partners
Hold
Maintains
$22$20
HoldMaintains$22$20-11.58%Jan 27, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
619.88M
from 642.82M
Decreased by -3.57%
Revenue Next Year
665.27M
from 619.88M
Increased by 7.32%
EPS This Year
-0.96
from -0.35
EPS Next Year
-0.71
from -0.96
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
490.49M516.41M618.73M610.79M642.82M619.88M665.27M
Revenue Growth
64.13%5.28%19.81%-1.28%5.24%-3.57%7.32%
EPS
-0.53-1.46-2.18-1.52-0.35-0.96-0.71
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1814
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High655.2M721.4M
Avg619.9M665.3M
Low595.5M622.3M

Revenue Growth

Revenue Growth20262027202820292030
High
1.9%
16.4%
Avg
-3.6%
7.3%
Low
-7.4%
0.4%

EPS Forecast

EPS20262027202820292030
High-0.56-0.16
Avg-0.96-0.71
Low-1.18-0.97

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.